IDL Diagnostics and concile at WHX Labs Dubai

Feb 20, 2026

Last week, IDL Diagnostics participated as an exhibitor at WHX Labs Dubai together with concile as part of the recently announced joint venture. The main focus is on delivering multiple biomarkers across different POC reader configurations and supporting infection, cardiac, oncology, hormones and chronic disease testing in a structured, platform-driven way.

Presentation of IDL Diagnostics Interim Report Q4 2025

Mar 2, 2026 | Financial News, News, Okategoriserade

CEO Anders Hultman and CFO Ellen Dittberner present the company’s Q4’25 results – February 26, 2026 Q4 Interview: Redeye talks with CEO Anders Hultman

Meet us at WHX Labs Dubai 10-13 February

Feb 2, 2026 | Events, News

We will be co-exhibiting together with our partner concile at Booth SA.A55. Come by our booth and learn more about our products and how quantitative point-of-care testing can be used to provide accurate and rapid results.

IDL Diagnostics participates at RedEye Theme Event Fight Cancer

Feb 2, 2026 | Events, News

On January 21st Redeye hosted a Fight Cancer 2026 theme event where CEO Anders Hultman presented about the company, market opportunities and the new strategic priority. See the presentation here

Events | News

IDL Diagnostics and concile at WHX Labs Dubai

Presentation of IDL Diagnostics Interim Report Q4 2025

Meet us at WHX Labs Dubai 10-13 February

IDL Diagnostics participates at RedEye Theme Event Fight Cancer

Contact us

Address

Follow us

Recent Posts

About

Products

Investors